SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-023724
Filing Date
2016-08-09
Accepted
2016-08-09 16:51:05
Documents
59
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 ARWR-Q3-20160630 arwr-10q_20160630.htm 10-Q 1693896
2 EX-31.1 arwr-ex311_9.htm EX-31.1 10927
3 EX-31.2 arwr-ex312_8.htm EX-31.2 11421
4 EX-32.1 arwr-ex321_7.htm EX-32.1 6762
5 EX-32.2 arwr-ex322_6.htm EX-32.2 7060
  Complete submission text file 0001564590-16-023724.txt   5205454

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arwr-20160630.xml EX-101.INS 787401
7 XBRL TAXONOMY EXTENSION SCHEMA arwr-20160630.xsd EX-101.SCH 41985
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arwr-20160630_cal.xml EX-101.CAL 51498
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arwr-20160630_def.xml EX-101.DEF 145167
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arwr-20160630_lab.xml EX-101.LAB 380005
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arwr-20160630_pre.xml EX-101.PRE 292810
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-21898 | Film No.: 161818647
SIC: 8731 Services-Commercial Physical & Biological Research